Phibro Animal Health Corp... (PAHC)
NASDAQ: PAHC
· Real-Time Price · USD
38.81
0.77 (2.02%)
At close: Sep 26, 2025, 3:59 PM
38.81
0.00%
After-hours: Sep 26, 2025, 04:10 PM EDT
Phibro Animal Health Revenue Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Vaccines Revenue | 38.57M | 33.38M | 33.17M | 32.03M | 31.99M | 32.92M | 29.73M | 26.22M | 26.2M | 22.77M | 23.02M |
| Vaccines Revenue Growth | +15.54% | +0.64% | +3.56% | +0.14% | -2.85% | +10.75% | +13.39% | +0.06% | +15.08% | -1.07% | n/a |
Revenue by Geography
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asia Pacific Revenue | 35.03M | 28.22M | 19.56M | 14.61M | 16.91M | 17.08M | 14.76M | 14.48M | 17.8M | 15.09M | 13.61M | 14.95M | 18.84M | 17.82M | 15.53M | 14.75M | 16.15M | 17.17M | 12.89M | 11.79M | 14.1M | 11.67M | 20.73M | 10.8M | 24.35M | 24.98M | 20.94M |
| Asia Pacific Revenue Growth | +24.12% | +44.31% | +33.89% | -13.63% | -0.98% | +15.72% | +1.93% | -18.65% | +17.96% | +10.84% | -8.97% | -20.61% | +5.70% | +14.78% | +5.25% | -8.64% | -5.97% | +33.18% | +9.31% | -16.34% | +20.81% | -43.71% | +91.97% | -55.65% | -2.50% | +19.25% | n/a |
| Emea Revenue | 57.61M | 38.91M | 32.59M | 31.13M | 32.41M | 33.17M | 29.52M | 26.88M | 32.3M | 28.17M | 27.83M | 29.52M | 55.33M | 45.05M | 48.01M | 42.66M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 122.86M | 127.75M | 116.09M |
| Emea Revenue Growth | +48.05% | +19.40% | +4.70% | -3.95% | -2.32% | +12.39% | +9.82% | -16.78% | +14.63% | +1.25% | -5.73% | -46.65% | +22.82% | -6.18% | +12.55% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -3.83% | +10.04% | n/a |
| Latin America And Canada Revenue | 84.07M | 70.75M | 72.67M | 71.15M | 70.17M | 53.65M | 65.18M | 58.7M | 59.9M | 53.88M | 53.82M | 52.25M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Latin America And Canada Revenue Growth | +18.82% | -2.64% | +2.14% | +1.40% | +30.78% | -17.69% | +11.04% | -2.00% | +11.17% | +0.11% | +3.01% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| United States Revenue | 201.99M | 209.94M | 184.44M | 143.55M | 153.68M | 159.31M | 140.48M | 131.29M | 145.05M | 148.53M | 149.39M | 135.8M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| United States Revenue Growth | -3.79% | +13.83% | +28.49% | -6.59% | -3.54% | +13.41% | +7.00% | -9.49% | -2.34% | -0.57% | +10.00% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 76.29M | 71.05M | 76.34M | 65.8M | 74.14M | 58.68M | 62.91M | 68.5M | 52.9M | 56.99M | 61.54M | 54.96M | 55.5M | 52.43M | 48.38M | 50.07M | 50.7M | 49.03M | 48.38M | 48.43M | 42.4M | 48.23M | 49.49M | 47.52M | 53.2M | 42.3M | 42.94M | 42.95M | 41.4M | 42.58M | 42.98M | 40.99M | 39.6M | 30.65M | 40.87M | 39.19M | 39.5M | 38.78M | 39.8M | 38.3M | 39.88M | 37.3M |
| Selling, General, and Administrative Revenue Growth | +7.37% | -6.92% | +16.02% | -11.25% | +26.34% | -6.73% | -8.15% | +29.49% | -7.17% | -7.40% | +11.97% | -0.97% | +5.85% | +8.38% | -3.37% | -1.25% | +3.40% | +1.36% | -0.12% | +14.22% | -12.09% | -2.55% | +4.16% | -10.68% | +25.76% | -1.48% | -0.03% | +3.75% | -2.76% | -0.94% | +4.84% | +3.52% | +29.22% | -25.02% | +4.30% | -0.79% | +1.85% | -2.54% | +3.90% | -3.97% | +6.94% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | 29.19M | n/a | n/a | n/a | 24.39M | n/a | n/a | n/a | 20.83M | n/a | n/a | n/a | 17.76M | n/a | n/a | n/a | 13.74M | n/a | n/a | n/a | 12.09M | n/a | n/a | n/a | 10M | n/a | n/a | n/a | 11.02M | n/a | n/a | n/a | 11.03M | n/a | n/a | n/a | 9.51M | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a |